Ceragenix Whistleblower's Malpractice Suit Shut Down

Law360, New York (June 14, 2012, 6:17 PM EDT) -- A former Ceragenix Pharmaceuticals Inc. executive cannot bring malpractice claims against an attorney who allegedly encouraged the bankrupt company to fire him in retaliation for reporting insider trading, a Colorado federal judge ruled Thursday.

U.S. Bankruptcy Judge Sidney B. Brooks denied Carl Genberg’s May 11 motion for leave to pursue malpractice claims against Boston-based attorney Marc Redlich. Ceragenix’s Chapter 7 trustee Jeanne Jagow declined to pursue the claims on her own, prompting Genberg to file suit June 1 while the motion was pending.

Jagow was justified...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.